189 related articles for article (PubMed ID: 26013439)
1. The prognostic factors and multiple biomarkers in young patients with colorectal cancer.
Wang MJ; Ping J; Li Y; Adell G; Arbman G; Nodin B; Meng WJ; Zhang H; Yu YY; Wang C; Yang L; Zhou ZG; Sun XF
Sci Rep; 2015 May; 5():10645. PubMed ID: 26013439
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance and Molecular Features of Colorectal Mucinous Adenocarcinomas: A Strobe-Compliant Study.
Wang MJ; Ping J; Li Y; Holmqvist A; Adell G; Arbman G; Zhang H; Zhou ZG; Sun XF
Medicine (Baltimore); 2015 Dec; 94(51):e2350. PubMed ID: 26705231
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumour deposit and perineural invasion status in colorectal cancer patients: a SEER-based population study.
Mayo E; Llanos AA; Yi X; Duan SZ; Zhang L
Histopathology; 2016 Aug; 69(2):230-8. PubMed ID: 26802566
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
5. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
Ye F; Jin P; Cai X; Cai P; Cai H
Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of p53 expression in patients with completely resected colorectal cancer.
Liu BW; Liu Y; Liu JR; Feng ZX; Liu T
Tumour Biol; 2014 Oct; 35(10):9893-6. PubMed ID: 24993094
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Features of Colorectal Cancer Patients Under the Age of 50: Recent Experience and Case-Control Study of Prognosis in a Japanese Cohort.
Nagai Y; Hata K; Kawai K; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Nozawa H; Yamaguchi H; Ishihara S; Watanabe T
Digestion; 2016; 93(4):272-9. PubMed ID: 27188463
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin is a marker of poor prognosis in colorectal cancer.
Kaprio T; Fermér C; Hagström J; Mustonen H; Böckelman C; Nilsson O; Haglund C
BMC Cancer; 2014 Jul; 14():493. PubMed ID: 25004863
[TBL] [Abstract][Full Text] [Related]
11.
Li AJ; Li HG; Tang EJ; Wu W; Chen Y; Jiang HH; Lin MB; Yin L
World J Gastroenterol; 2018 Feb; 24(5):631-640. PubMed ID: 29434452
[TBL] [Abstract][Full Text] [Related]
12. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of p53 positive in colorectal cancer: A retrospective cohort study.
Wang P; Liang J; Wang Z; Hou H; Shi L; Zhou Z
Tumour Biol; 2017 May; 39(5):1010428317703651. PubMed ID: 28468582
[TBL] [Abstract][Full Text] [Related]
14. The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ-Ⅲ colorectal cancer.
Wei Y; Zhang X; Wang G; Zhou Y; Luo M; Wang S; Hong C
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e243-e251. PubMed ID: 29532611
[TBL] [Abstract][Full Text] [Related]
15. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
[TBL] [Abstract][Full Text] [Related]
16. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Features and Survival Outcomes of Colorectal Cancer in Young Versus Elderly: A Population-Based Cohort Study of SEER 9 Registries Data (1988-2011).
Wang R; Wang MJ; Ping J
Medicine (Baltimore); 2015 Sep; 94(35):e1402. PubMed ID: 26334895
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
[TBL] [Abstract][Full Text] [Related]
19. Young-age onset colorectal cancer in Brazil: Analysis of incidence, clinical features, and outcomes in a tertiary cancer center.
Silva ACB; Vicentini MFB; Mendoza EZ; Fujiki FK; da Fonseca LG; Braghiroli MIFM; Hoff PM
Curr Probl Cancer; 2019 Oct; 43(5):477-486. PubMed ID: 30826126
[TBL] [Abstract][Full Text] [Related]
20. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.
Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J
Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
